Venture Capital Insights, Trends & Strategies for Founders and Investors

Venture Capital Insiders, practical intelligence for decision-makers

We help founders, operators, and investors translate venture capital theory into actions that improve outcomes - from tighter fundraising narratives to faster deal execution.

Our editorial approach is built on repeatable frameworks, clear terminology, and real-world constraints like timelines, committee dynamics, and risk-adjusted returns.

Use the site to benchmark your process, sharpen your strategy, and make confident moves with less noise and more signal.

What you will get from our coverage

Decision-ready insights for IC memos, diligence, and portfolio support.
Frameworks that improve speed, consistency, and ROI of your workflow.
Strategy coverage across markets, signals, and capital allocation.
Trusted, jargon-aware explanations for stakeholders and teammates.
Curated reading paths across Venture Capital Essentials and Investment Strategies.

Explore Trends and Insights

Current trends

AI due diligence in 2026: what the IC actually needs to see beyond the demo

Evaluating Startups for Investment

•

12/06/2026

AI due diligence in 2026: what the IC actually needs to see beyond the demo

A partner level framework for AI startup due diligence beyond the demo, covering data moats, inference economics, IP risk, and IC ready checklists for investors.

The founder's cap table audit: three structures that kill optionality before Series B

Evaluating Startups for Investment

•

12/06/2026

The founder's cap table audit: three structures that kill optionality before Series B

Cybersecurity's moat problem: why most startups lose pricing power after Series B

Evaluating Startups for Investment

•

05/06/2026

Cybersecurity's moat problem: why most startups lose pricing power after Series B

The dry powder paradox: why $300B deployed in Q1 doesn't mean the market is loose

Current Trends in Venture Capital

•

03/06/2026

The dry powder paradox: why $300B deployed in Q1 doesn't mean the market is loose

Venture Capital in Emerging Markets

•

12/06/2026

Venture capital in emerging markets: where dealflow quality is outpacing the capital

Spotlight

The acqui-hire is dead: M&A buyers in 2026 pay for distribution, not talent

Evaluating Startups for Investment

•

01/06/2026

The acqui-hire is dead: M&A buyers in 2026 pay for distribution, not talent

Why distribution, customer bases and user engagement now drive startup M&A value more than acqui-hire, with concrete metrics, cohort examples and data on technology acquisitions.

Rockets as data centers: why Index Ventures led Cowboy Space's $275M round at a $2B valuation

Evaluating Startups for Investment

•

25/05/2026

Rockets as data centers: why Index Ventures led Cowboy Space's $275M round at a $2B valuation

Analysis of Cowboy Space’s orbital computing model, NVIDIA’s space-qualified AI hardware, and the strategic playbook for investors treating rocket-based data centers as core cloud infrastructure rather than niche spacetech.

The pre-mortem framework: how to run due diligence on your own startup before the IC does

Evaluating Startups for Investment

•

27/05/2026

The pre-mortem framework: how to run due diligence on your own startup before the IC does

Learn how to build a startup self due diligence framework, structure a high quality data room, and run a seven domain pre-mortem that improves valuation, deal terms, and investor trust.

Sierra at $15B: Bret Taylor's $950M bet that enterprise AI agents are a platform, not a feature

Emerging Technologies and Markets

•

22/05/2026

Sierra at $15B: Bret Taylor's $950M bet that enterprise AI agents are a platform, not a feature

Sierra’s reported $950M funding round and $15B valuation are redefining benchmarks for enterprise AI agent platforms, reshaping early-stage deal flow, capital allocation, and strategic positioning across the enterprise AI stack.

Isomorphic Labs raises $2.1B: what the largest AI drug discovery round tells allocators about biotech's next chapter

Emerging Technologies and Markets

•

18/05/2026

Isomorphic Labs raises $2.1B: what the largest AI drug discovery round tells allocators about biotech's next chapter

Analysis of Isomorphic Labs’ reported $2.1B Series B, what it signals for AI drug discovery venture capital funding, and how allocators should rethink risk, portfolio construction and sovereign capital in AI native biopharmaceutical platforms.

Five years of negative LP cash flow: the distribution crisis reshaping fund strategy

Key Challenges in Venture Capital

•

20/05/2026

Five years of negative LP cash flow: the distribution crisis reshaping fund strategy

Venture capital LPs face a 45 billion dollar net cash flow deficit, a severe denominator effect, and longer times to first distribution. Explore how GPs are using continuation vehicles, NAV loans, and structured liquidity, and what this new environment means for emerging managers and fundraising.

How to break into venture capital in 2026: the resume, the thesis, and the deal you bring

Recruitment Process and Tips

•

29/05/2026

How to break into venture capital in 2026: the resume, the thesis, and the deal you bring

Detailed guide to breaking into venture capital in 2026, covering real entry paths, sourcing over pedigree, resumes, sector theses, networking, recruiting dynamics, and key data on VC careers.

Mid-year VC trends review: the thesis shifts founders should already be pricing in

Current Trends in Venture Capital

•

14/05/2026

Mid-year VC trends review: the thesis shifts founders should already be pricing in

Mid-year venture capital trends in 2024: how AI megadeals, sector rotation, LP allocation shifts, and a higher cost of capital are reshaping deal pacing, term sheets, and summer fundraising strategy for CEOs.

Buy over build: why large corporates are paying venture premiums in 2026

Current Trends in Venture Capital

•

15/05/2026

Buy over build: why large corporates are paying venture premiums in 2026

Learn how a corporate buy over build M&A strategy helps CEOs accelerate innovation, justify strategic premiums, and turn corporate development into a repeatable growth engine while managing regulatory risk.

The IPO window is cracking open: what corp dev teams should price in

Current Trends in Venture Capital

•

13/05/2026

The IPO window is cracking open: what corp dev teams should price in

How the 2026 IPO–M&A window reshapes corporate development: reserve price math, valuation discipline, global comps and board-level playbooks for CEOs competing with private equity and public markets.

Secondaries as a base layer: how continuation vehicles rewrote the VC liquidity map

Innovations in VC Financing

•

11/05/2026

Secondaries as a base layer: how continuation vehicles rewrote the VC liquidity map

How VC secondaries and continuation vehicles are reshaping venture capital, liquidity and governance — a strategic playbook for CEOs navigating secondary markets.

The corporate venture capital playbook: building an arm the board will actually fund

Types of Venture Funds

•

08/05/2026

The corporate venture capital playbook: building an arm the board will actually fund

Learn how to design a corporate venture capital strategy that avoids innovation theatre, with real CVC case studies, mandate design tips, governance KPIs and founder alignment tactics for CEOs, CFOs and boards.

by Ava Henderson

Lockheed Martin Ventures doubles to $1B: the corporate venture playbook gets a $600M upgrade

Types of Venture Funds

•

04/05/2026

Lockheed Martin Ventures doubles to $1B: the corporate venture playbook gets a $600M upgrade

Lockheed Martin’s 1B fund signals a new era for corporate venture capital in defense, with CVCs competing on terms, dual-use theses, and board-level strategic impact.

by Leonardo Agostini

Biotech venture in 2026: why the $600M rounds are not a bubble

Current Trends in Venture Capital

•

06/05/2026

Biotech venture in 2026: why the $600M rounds are not a bubble

Biotech venture capital trends can look frothy, but late-stage mega rounds are really structured options on clinical trials and pharma M&A. Learn how Phase 2 costs, pharma acquirers, platform versus program bets, and geopolitics shape biotech valuations for CEOs and generalist VCs.

by Eloise Adler

Diversify then concentrate: the portfolio construction rule every emerging manager gets wrong

Key Challenges in Venture Capital

•

07/05/2026

Diversify then concentrate: the portfolio construction rule every emerging manager gets wrong

Learn how venture capital portfolio construction really works: why 30+ startups per VC fund, 50–70% reserves, and disciplined follow-on strategy matter for CEOs raising capital.

by Harold McBride

Series A funding requirements in 2026: the real bar founders need to clear

The Process of Venture Funding

•

12/05/2026

Series A funding requirements in 2026: the real bar founders need to clear

Detailed guide to modern Series A funding requirements: ARR and growth benchmarks, burn multiple expectations, team and governance signals, market-fit evidence, and how these metrics translate into real term-sheet dynamics for founders.

The IC memo anatomy: what partners actually read before the vote

The Process of Venture Funding

•

03/05/2026

The IC memo anatomy: what partners actually read before the vote

How CEOs should read and shape a VC investment committee memo, from risk narrative and valuation to bear cases, governance, and long term capital strategy.

by Jean-Christophe Durand

Zero Shot and the new emerging manager template: what OpenAI alumni funds teach allocators

Types of Venture Funds

•

27/04/2026

Zero Shot and the new emerging manager template: what OpenAI alumni funds teach allocators

How emerging manager venture funds like Zero Shot are reshaping operator-led VC, LP diligence, and CEO-investor dynamics, with concrete mechanics and strategic implications.

by Wan-Ling Chen

The 2026 term sheet pendulum: why participating preferred is back on the table

The Process of Venture Funding

•

28/04/2026

The 2026 term sheet pendulum: why participating preferred is back on the table

Participating preferred term sheets are reshaping venture capital outcomes. Learn how liquidation preferences, participation rights, and bridge round terms shift value between preferred and common shareholders, and how founders and boards can negotiate smarter.

by Wan-Ling Chen

Term sheet negotiation tips that actually move the needle for founders

The Process of Venture Funding

•

07/05/2026

Term sheet negotiation tips that actually move the needle for founders

Practical term sheet negotiation guide for CEOs: how liquidation preferences, participation, pay-to-play, board control, and protective provisions really shape founder dilution and exit outcomes, with data-backed benchmarks and example clauses.

by Wan-Ling Chen

The Strategic Implications of Houzz's Initial Public Offering

Elevating Financial Growth with Summit Capital Advance

Impact Investing and ESG Considerations

•

12/06/2025

Elevating Financial Growth with Summit Capital Advance

Legal and Regulatory Environment

•

12/06/2025

Understanding the legal and regulatory environment in venture capital

The Future of Venture Capital

•

12/06/2025

Navigating the Path to an Attentive IPO

Life in a venture fund: the story behind salary and compensation

Salary and Compensation Structures

•

12/06/2025

Life in a venture fund: the story behind salary and compensation

Factris: revolutionizing finance automation for small and medium-sized businesses

Innovations in VC Financing

•

12/06/2025

Factris: revolutionizing finance automation for small and medium-sized businesses

Venture capital ecosystem: exploring global trends and key players

Global VC Landscape and Key Players

•

12/06/2025

Venture capital ecosystem: exploring global trends and key players

Early-Stage vs. Late-Stage Investing

•

12/06/2025

Early-stage vs late-stage investing: a deep dive into strategic choices

Unlocking the Potential of Government-Sponsored Venture Capital

Legal and Regulatory Environment

•

12/06/2025

Unlocking the Potential of Government-Sponsored Venture Capital

Navigating Strategic Growth with Columbia Pacific Advisors

Emerging Technologies and Markets

•

12/06/2025

Navigating Strategic Growth with Columbia Pacific Advisors

Crafting a Winning Investment Memo for Venture Capital Success

The Process of Venture Funding

•

12/06/2025

Crafting a Winning Investment Memo for Venture Capital Success

Exploring Opportunities with a Greenoaks Capital Internship

Recruitment Process and Tips

•

12/06/2025

Exploring Opportunities with a Greenoaks Capital Internship

Exploring the Strategic Impact of Bain Capital's Double Impact Approach

Impact Investing and ESG Considerations

•

12/06/2025

Exploring the Strategic Impact of Bain Capital's Double Impact Approach

Investing in Renewable Energy: A Venture Capital Perspective

Impact Investing and ESG Considerations

•

12/06/2025

Investing in Renewable Energy: A Venture Capital Perspective

Unlocking the Secrets of Venture Capital Compensation: A Guide for Industry Professionals

Salary and Compensation Structures

•

12/06/2025

Unlocking the Secrets of Venture Capital Compensation: A Guide for Industry Professionals

Navigating Strategic Challenges with Centiva Capital

Key Challenges in Venture Capital

•

12/06/2025

Navigating Strategic Challenges with Centiva Capital

Venture Capital Essentials

Startup valuation methods in 2026: when Berkus, DCF, and scorecard actually apply

Evaluating Startups for Investment

•

08/05/2026

Startup valuation methods in 2026: when Berkus, DCF, and scorecard actually apply

A CEO level guide to startup valuation methods, from Berkus and Scorecard to DCF, comparables, and AI era distortions, with practical tactics for venture rounds.

How venture capital funds actually work: the mechanics behind the pitch deck theatre

Understanding Venture Capital

•

04/05/2026

How venture capital funds actually work: the mechanics behind the pitch deck theatre

A deep, practical guide for CEOs and aspiring VCs on how venture capital funds work, from LP-GP structures and fees to J-curves, portfolio construction, and returns.

by Tanisha Patel

Life in a Venture Fund

How to turn investor relations vacancies into a strategic advantage for your company

Understanding Venture Capital

•

19/03/2026

How to turn investor relations vacancies into a strategic advantage for your company

How CEOs can turn investor relations vacancies into a strategic advantage, aligning finance, reporting, and capital markets while strengthening long term leadership.

by Harold McBride

Strategic accounting software for venture capital firms seeking sharper control

Understanding Venture Capital

•

15/03/2026

Strategic accounting software for venture capital firms seeking sharper control

How CEOs can turn accounting software for venture capital into a strategic platform for scalable funds, real-time reporting, and investor trust.

by Eloise Adler

Investment Strategies

Crusoe at $10B: pricing AI infrastructure when the SaaS comparables stop working

Evaluating Startups for Investment

•

23/04/2026

Crusoe at $10B: pricing AI infrastructure when the SaaS comparables stop working

Why PayPal’s 300 million technology restructuring is a pivotal test for digital payments leadership

Emerging Technologies and Markets

•

18/03/2026

Why PayPal’s 300 million technology restructuring is a pivotal test for digital payments leadership

How synthetic biology venture capital firms are reshaping biotech company strategy

Understanding Venture Capital

•

17/03/2026

How synthetic biology venture capital firms are reshaping biotech company strategy

What m a news japan today means for your next strategic move

Geographical Strategies in VC

•

24/02/2026

What m a news japan today means for your next strategic move

Trends and Insights

$Founders, read the megadeal math: what concentrated AI funding actually does to your round$

Current Trends in Venture Capital

•

24/04/2026

Founders, read the megadeal math: what concentrated AI funding actually does to your round

AI funding concentration is reshaping venture capital. Learn how LP reallocation, mega-rounds, and changing acquirer behavior affect follow-on capital, board expectations, and exit math—and what founders can do to keep negotiating power.

by Leonardo Agostini

Q1 2026 funding roundup: the deals, funds, and valuations that reset the benchmarks

Current Trends in Venture Capital

•

21/04/2026

Q1 2026 funding roundup: the deals, funds, and valuations that reset the benchmarks

Detailed Q1 2026 VC funding roundup for CEOs, covering valuations, round sizes, AI and infrastructure trends, sector shifts, exits, and M&A signals across global venture capital markets.

by Tanisha Patel

Venture Capital Ecosystem

What brightflag acquired by Wolters Kluwer means for corporate legal strategy

The Role of Angel Investors and Incubators

•

10/04/2026

What brightflag acquired by Wolters Kluwer means for corporate legal strategy

Analysis for CEOs on what brightflag acquired by Wolters Kluwer means for corporate legal strategy, capital allocation, risk governance, and legal technology choices.

by Elias Raphael

Emerging Technologies and Markets

•

18/03/2026

Why PayPal’s 300 million technology restructuring is a pivotal test for digital payments leadership

An in depth analysis of PayPal’s 300 million technology restructuring and what CEOs can learn about digital payments strategy, risk, and large scale transformation.

by Leonardo Agostini